tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:AZN Stock Latest News

AstraZeneca’s New Study on AZD4954: Potential Breakthrough in Cardiovascular Treatment
Company AnnouncementsAstraZeneca’s New Study on AZD4954: Potential Breakthrough in Cardiovascular Treatment
1d ago
AZN
AstraZeneca’s New Trial on Benralizumab: A Potential Game-Changer for Pediatric Eosinophilic Diseases
PremiumCompany Announcements
AstraZeneca’s New Trial on Benralizumab: A Potential Game-Changer for Pediatric Eosinophilic Diseases
1d ago
AZN
AstraZeneca’s AZD5004 Study: A New Hope for Type 2 Diabetes Treatment?
PremiumCompany Announcements
AstraZeneca’s AZD5004 Study: A New Hope for Type 2 Diabetes Treatment?
1d ago
AZN
AstraZeneca’s Ravulizumab Study: A Potential Game-Changer for gMG Treatment
PremiumCompany Announcements
AstraZeneca’s Ravulizumab Study: A Potential Game-Changer for gMG Treatment
1d ago
AZN
AstraZeneca’s Promising Phase II Study on AZD7798 for Crohn’s Disease
PremiumCompany Announcements
AstraZeneca’s Promising Phase II Study on AZD7798 for Crohn’s Disease
1d ago
AZN
AstraZeneca’s Benralizumab Study: Real-World Insights for Severe Asthma
PremiumCompany AnnouncementsAstraZeneca’s Benralizumab Study: Real-World Insights for Severe Asthma
1d ago
AZN
AstraZeneca’s SLE Study in Russia: A Potential Game Changer for Autoimmune Insights
Premium
Company Announcements
AstraZeneca’s SLE Study in Russia: A Potential Game Changer for Autoimmune Insights
1d ago
AZN
AstraZeneca’s Phase I Study on AZD6234: A Potential Game-Changer in Obesity Treatment
Premium
Company Announcements
AstraZeneca’s Phase I Study on AZD6234: A Potential Game-Changer in Obesity Treatment
1d ago
AZN
PRXL
AstraZeneca’s Phase 3 COPD Study: A Potential Game-Changer for Benralizumab
PremiumCompany Announcements
AstraZeneca’s Phase 3 COPD Study: A Potential Game-Changer for Benralizumab
1d ago
AZN
AstraZeneca’s Anifrolumab Study: A Potential Game-Changer for SLE Treatment
PremiumCompany Announcements
AstraZeneca’s Anifrolumab Study: A Potential Game-Changer for SLE Treatment
1d ago
AZN
AstraZeneca’s Phase III Trial: A Potential Game Changer in Breast Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s Phase III Trial: A Potential Game Changer in Breast Cancer Treatment
1d ago
AZN
AstraZeneca’s New CAR T-Cell Therapy Study: A Potential Game-Changer for Refractory SLE
PremiumCompany Announcements
AstraZeneca’s New CAR T-Cell Therapy Study: A Potential Game-Changer for Refractory SLE
1d ago
AZN
AstraZeneca’s Tozorakimab Study: A Potential Game-Changer for Asthma Treatment?
PremiumCompany AnnouncementsAstraZeneca’s Tozorakimab Study: A Potential Game-Changer for Asthma Treatment?
1d ago
AZN
AstraZeneca’s Real-World Study on Dapagliflozin: Implications for Heart Failure Treatment
Premium
Company Announcements
AstraZeneca’s Real-World Study on Dapagliflozin: Implications for Heart Failure Treatment
1d ago
AZN
AstraZeneca’s PRIMULA Lac Study: A Key Step in Anifrolumab’s Market Journey
Premium
Company Announcements
AstraZeneca’s PRIMULA Lac Study: A Key Step in Anifrolumab’s Market Journey
1d ago
AZN
AstraZeneca’s CASPIAN Study: A Promising Update in Lung Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s CASPIAN Study: A Promising Update in Lung Cancer Treatment
1d ago
AZN
AstraZeneca’s Latest Study on Dato-DXd for NSCLC: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Latest Study on Dato-DXd for NSCLC: Key Insights for Investors
1d ago
AZN
AstraZeneca’s Promising NSCLC Study: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s Promising NSCLC Study: A Potential Game-Changer in Cancer Treatment
1d ago
AZN
AstraZeneca’s Pediatric Hyperkalaemia Study: A Potential Game-Changer
PremiumCompany Announcements
AstraZeneca’s Pediatric Hyperkalaemia Study: A Potential Game-Changer
1d ago
AZN
AstraZeneca’s AQUALIS Study: Enhancing CLL Patient Quality of Life with Acalabrutinib
PremiumCompany AnnouncementsAstraZeneca’s AQUALIS Study: Enhancing CLL Patient Quality of Life with Acalabrutinib
1d ago
AZN
AstraZeneca’s DESTINY-Endometrial01 Study: A New Hope for Endometrial Cancer Treatment
Premium
Company Announcements
AstraZeneca’s DESTINY-Endometrial01 Study: A New Hope for Endometrial Cancer Treatment
1d ago
AZN
AstraZeneca’s REBECCA Study: Real-World Insights into Early Breast Cancer Management
Premium
Company Announcements
AstraZeneca’s REBECCA Study: Real-World Insights into Early Breast Cancer Management
1d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >